Profile data is unavailable for this security.
About the company
Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine active pharmaceutical ingredients (API) and imaging contrast agents for medical radiology. It focuses on vertically integrating the barium and iodine contrast markets. In addition, Voyageur is pursuing the development of new endo fullerene drugs. Its products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. At the core of its operations, the Company also owns a 100% interest in the Frances Creek Project, which boasts a mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.
- Revenue in CAD (TTM)11.04k
- Net income in CAD-3.13m
- Incorporated2008
- Employees--
- LocationVoyageur Pharmaceuticals LtdDome Tower 800, 333 7 Ave. S.W.CALGARY T2P 2Z1CanadaCAN
- Phone+1 (403) 923-5944
- Fax+1 (403) 508-2670
- Websitehttps://voyageurpharmaceuticals.ca/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vitura Health Ltd | 120.43m | 3.18m | 27.67m | 119.00 | 7.96 | 0.5908 | 5.37 | 0.2298 | 0.0054 | 0.0054 | 0.2034 | 0.0728 | 1.69 | 16.43 | 10.46 | -- | 4.11 | 12.75 | 5.72 | 17.62 | 27.21 | 30.97 | 2.43 | 6.06 | 1.05 | 9.50 | 0.2009 | -- | 0.1341 | 298.23 | -5.35 | -- | 129.38 | -- |
| Global Pharmatech Inc. | 4.34m | -3.06m | 28.33m | 217.00 | -- | 0.1459 | -- | 6.53 | -0.0964 | -0.0964 | 0.1367 | 0.3428 | 0.2292 | 1.59 | 3.57 | 14,649.77 | -16.44 | -- | -22.55 | -- | 46.21 | -- | -71.75 | -- | 1.62 | -9.87 | 0.2223 | -- | 32.43 | -- | -142.03 | -- | -- | -- |
| Voyageur Pharmaceuticals Ltd | 11.04k | -3.13m | 28.57m | -- | -- | 19.78 | -- | 2,588.22 | -0.0197 | -0.0197 | 0.00007 | 0.0081 | 0.0037 | 0.17 | 0.1428 | -- | -103.95 | -78.90 | -250.45 | -135.25 | -25.63 | -- | -28,307.25 | -- | 0.5081 | -- | 0.027 | -- | -- | -- | -21.99 | -- | -1.10 | -- |
| Delta-Fly Pharma Inc | 0.00 | -14.53m | 28.82m | 13.00 | -- | 14.89 | -- | -- | -153.26 | -153.26 | 0.00 | 17.06 | 0.00 | -- | -- | 0.00 | -288.88 | -88.06 | -369.76 | -97.02 | -- | -- | -- | -1,051.54 | -- | -- | 0.00 | -- | -- | -- | -20.41 | -- | -61.24 | -- |
| Cilo Cybin Holdings Ltd | 1.59m | -18.27m | 29.60m | -- | -- | 4.31 | -- | 18.64 | -2.88 | -2.88 | 0.2619 | 0.3477 | 0.2187 | -- | 2.55 | -- | -251.63 | -- | -260.31 | -- | 60.64 | -- | -1,150.51 | -- | 16.04 | -- | 0.0532 | -- | -- | -- | -228.61 | -- | -- | -- |
| Brooks Laboratories Ltd | 13.31m | 3.24m | 29.62m | 323.00 | 9.17 | -- | 8.53 | 2.23 | 7.32 | 7.32 | 30.45 | -- | -- | -- | -- | 2,750,638.00 | -- | -14.21 | -- | -23.39 | 38.75 | 25.99 | 24.31 | -25.22 | -- | -- | -- | -- | 3.86 | 3.45 | 49.13 | -- | -18.61 | -- |
| Quest Laboratories Ltd | -1.50bn | -1.50bn | 29.64m | 50.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 25.92 | -- | 34.40 | -- | -- | -- |
